Results 41 to 50 of about 141,328 (115)
Emerging advances in spinal cord injury: An introductory overview
Spinal cord injury (SCI) remains a devastating condition with limited treatment options. This Focus Issue highlights recent clinical and translational advances across the continuum of SCI care from prehospital coordination to novel therapeutics.
Michael G. Fehlings +3 more
doaj +1 more source
Background: Chiari malformation type I (CM1) with syringomyelia caused by supratentorial lesions is extremely rare, and the mechanism has not been well explained.
Chengjian Lou +4 more
doaj +1 more source
Patients with Parkinson’s disease almost uniformly experience sleep disorders. Sleep disorders have been linked to the severity of cognitive impairment, which is also a comorbidity with Parkinson’s disease psychosis (PDP).
Ana Berrio +3 more
doaj +1 more source
microRNAs (miRNAs) have been verified as molecular targets for regulating tumor proliferation, invasion, and metastasis in tumor progression. However, the relationship between miRNAs and cellular energy metabolism in breast cancer still needs to be ...
Liping Zhang +6 more
semanticscholar +1 more source
BackgroundPreoperative identification of diffuse glioma boundaries remains an unsolved problem of modern neurooncology. The main problem is the heterogeneity of the tumor being manifested by simultaneous presence of both contrast-enhancing and non ...
Rustam Talybov +11 more
doaj +1 more source
Theranostic application of miR-429 in HER2+ breast cancer
Human epidermal growth factor receptor 2 (HER2) is overexpressed/amplified in one third of breast cancers (BCs), and is associated with the poorer prognosis and the higher metastatic potential in BC.
C. Cava +9 more
semanticscholar +1 more source
BackgroundCognitive impairment and depression frequently occur after spinal cord injury (SCI) and adversely affect functional independence and quality of life. There is a lack of research in addressing this important area in SCI rehabilitation/care.
Yule Hu +8 more
doaj +1 more source
Research progress of artificial intelligence in moyamoya disease
Moyamoya disease (MMD), a chronic, progressive cerebrovascular disorder of unknown etiology, presents significant diagnostic and therapeutic challenges in clinical practice.
Huimin Huang +4 more
doaj +1 more source
Switch from fingolimod to ozanimod for safety or intolerance reasons
Introduction: Ozanimod is a new-generation sphingosine-1-phosphate (S1P) modulator, approved for the treatment of multiple sclerosis (MS), offering higher selectivity for S1P receptor 1 and 5 (SPR1-5), minimizing potential safety concerns related to S1P3
Elisabetta Signoriello +7 more
doaj +1 more source
Sphenopalatine ganglion stimulation for the treatment of trigeminal neuropathic pain
IntroductionUnlike idiopathic trigeminal neuralgia, which can be treated with conventional neurosurgical methods such as microvascular decompression, radiofrequency rhizotomy of the Gasser ganglion, or stereotactic radiosurgery, trigeminal neuropathic ...
Paweł Sokal +7 more
doaj +1 more source

